The single-use biopsy devices market is projected to grow from USD 2.0 billion in 2026 to USD 4.7 billion by 2036, at a CAGR of 9.0%. Core needle biopsy will dominate with a 51.0% market share, while oncology will lead the applications segment with a 66.0% share.